A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
PHASE2
Head and neck cancer is the malignant tumor with the highest morbidity and ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer
PHASE2
Investigators will determine whether a treatment paradigm of up-front neck ...
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
PHASE3
The purpose of study is to compare bladder intact-event free survival (BI-E...